Interesting news from Pfizer today. It seems that some testing that was done shows that the cholesterol reducing medication Lipitor was very affective at increasing the blood and oxygen to the hearts of people with Chronic Angina.
Pfizer said Tuesday that a new study of its cholesterol-lowering drug Lipitor, 80 mg, showed unexpectedly significant reduction in myocardial ischemia in patients with chronic stable angina.
Myocardial ischemia is a condition defined by insufficient blood supply and oxygen to the heart. Angina is chest pain or discomfort that occurs when an area of the heart muscle doesn’t get enough oxygen-rich blood.
The New York-based pharmaceutical giant said Lipitor reduced the average number of ischemic events by nearly 70% and total duration of events by more than 60% from baseline to week 18 of the study, and sustained the effects until the end of the trial at week 26.
In 60% patients treated with Lipitor, all ischemic events were completely eliminated by the end of the study, the company said.
The results were presented at the annual meeting of the American College of Cardiology.
This is big news for a great many people in the population that have issues with Angina
Looking to make a change and lose some weight? I have reviewed the top diet on the internet and you can go and read over 200 comments people have made about why this diet has worked well for them, as well as some of the problems.
Tags: american college of cardiology, angina, chest pain, cholesterol, chronic stable angina, insufficient blood supply, lipitor, myocardial ischemia, New York, pfizer, pharmaceutical giant, the American College
Entries (RSS)